Fig. 1From: The effects of oxaliplatin-based adjuvant chemotherapy in high-risk stage II colon cancer with mismatch repair-deficient: a retrospective studyDisease-free survival in patients with stage II dMMR colon cancers by high-risk factor statusBack to article page